Catalina A. Andrade
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Human respiratory syncytial virus causes maternal inflammation in pregnant mice and behavioral alterations in the offspring.
Journal: Brain, behavior, and immunity
Published: September 05, 2025
Variability in IFN Secretion in Response to the Human Metapneumovirus CZ0107 Strain: A Comparative Study in BALB/c and C57BL/6 Mouse Models.
Journal: Journal of medical virology
Published: July 07, 2025
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection.
Journal: Expert review of anti-infective therapy
Published: September 13, 2024
A molecular perspective for the development of antibodies against the human respiratory syncytial virus.
Journal: Antiviral research
Published: October 07, 2023
Contribution of viral and bacterial infections to senescence and immunosenescence.
Journal: Frontiers in cellular and infection microbiology
Published: May 25, 2023
Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults.
Journal: Frontiers in immunology
Published: May 02, 2023
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.
Journal: mBio
Published: November 16, 2022
LAG-3 Contribution to T Cell Downmodulation during Acute Respiratory Viral Infections.
Journal: Viruses
Published: October 11, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.
Journal: eLife
Published: June 29, 2022
Increased Heme Oxygenase 1 Expression upon a Primary Exposure to the Respiratory Syncytial Virus and a Secondary Mycobacterium bovis Infection.
Journal: Antioxidants (Basel, Switzerland)
Published: June 02, 2022
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial.
Journal: medRxiv : the preprint server for health sciences
Published: April 20, 2022
Last Updated: 09/26/2026